Investing
The Series B marks the company's third funding round in less than a year.
The company will use the funds to enhance its platform, grow its workforce and expand partnerships with health systems to automate medication approval workflows.
The company will use the funds to accelerate development of its AI precision health platform.
The company will use the funds to scale its platform, hire engineers and data scientists, deepen clinical integrations and speed the deployment of custom AI agents.
The company's lab allows AI systems to create, evaluate and deploy new machine learning models with minimal human intervention.
The latest funding round brings the company's total raise to approximately $100 million.
Nadia Care will use the funds to expand access to its maternal care platform in the D.C., Maryland and Tennessee markets.
Also, Medtech Global has integrated a clinical documentation AI into its popular patient management system in New Zealand.
Science Corporation, a competitor of Elon Musk's Neuralink, offers a brain-computer interface retinal implant designed to restore vision in patients with macular degeneration.
The Massachusetts-based company will use the funds to advance its Spectris neurotechnology platform that uses visual and auditory stimulation to treat Alzheimer's disease.